Related references
Note: Only part of the references are listed.Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders
Biba R. Stanton et al.
JOURNAL OF NEUROLOGY (2013)
A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease
Laura L. Frakey et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Methylphenidate for Apathy and Functional Status in Dementia of the Alzheimer Type
Prasad R. Padala et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Apathy Diagnosis, Assessment, and Treatment in Alzheimer's Disease
Philippe H. Robert et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE)
Serge Gauthier et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Depression and apathy in dementia: Same syndrome or different constructs? A critical review
P. Tagariello et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review
Rosa L. Drijgers et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders
P. Robert et al.
EUROPEAN PSYCHIATRY (2009)
Effect of a Serotonin Reuptake Inhibitor on Irritability, Apathy, and Psychotic Symptoms in Patients With Alzheimer's Disease
Haroon Siddique et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Methylphenidate for the treatment of apathy in Alzheimer disease: Prediction of Response Using Dextroamphetamine Challenge
Nathan Herrmann et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Effectiveness and Safety of Donepezil in Hispanic Patients with Alzheimer's Disease: A 12-Week Open-Label Study
Oscar L. Lopez et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2008)
Effects of Ginkgo biloba Extract EGb 761® on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial
Andrey Scripnikov et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2007)
EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease
S. Gauthier et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study
Kenneth Rockwood et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits
R Levy et al.
CEREBRAL CORTEX (2006)
A naturalistic study of galantamine for Alzheimer's disease
Henry Brodaty et al.
CNS DRUGS (2006)
Early behavioral symptoms and course of Alzheimer's disease
MF Weiner et al.
ACTA PSYCHIATRICA SCANDINAVICA (2005)
Metabolic patterns associated with the clinical response to galantamine therapy - A fludeoxyglucose F 18 positron emission tomographic study
MS Mega et al.
ARCHIVES OF NEUROLOGY (2005)
Efficacy of donepezil in early-stage Alzheimer disease - A randomized placebo-controlled trial
B Seltzer et al.
ARCHIVES OF NEUROLOGY (2004)
Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease
M Tanaka et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Apathy in Alzheimer's disease
AM Landes et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)